Zerodha (Trading Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
Comparision between DSJ keep Learning Rights Issue 2024 and Solara Active Pharma Sciences Rights Issue 2024.
Find important information like Listing Exchange, Terms of payment and Entitlement Ratio for DSJ keep Learning Rights Issue 2024 and Solara Active Pharma Sciences Rights Issue 2024. DSJ keep Learning Rights Issue 2024 is listed on BSE while Solara Active Pharma Sciences Rights Issue 2024 is listed on BSE, NSE.
| DSJ keep Learning Limited | Solara Active Pharma Sciences Ltd | |
|---|---|---|
| Logo |  |
 |
| Listing At | BSE | BSE, NSE |
| Terms of Payment | The full amount of Re 1/- Equity share is payable on application by the Eligible Shareholder/Applicant. |
Issue Price of Rs.375/- per share is payable as Rs.131.25 per share on Application. The remaining amount will be called within 24 months from the date of allotment in the Issue or within such extended period as may be determined by the Board or Rights Issue Committee of the Company at its sole discretion from time to time. |
| Entitlement | 7 Rights Equity Share(s) for every 9 fully paid-up Equity Shares held on Record Date | 1 Rights Equity Share(s) for every 3 fully paid-up Equity Shares held on Record Date |
| Application Form | Application Form  |
Application Form |
| Letter of Offer | Letter of Offer |
Letter of Offer |
| Registrar | Link Intime India Private Ltd | Cameo Corporate Services Limited |
| Lead Managers | Choice Capital Advisors Pvt Ltd |
The issue size of DSJ keep Learning Rights Issue 2024 rights issue is ₹6.81 Crores, whereas Solara Active Pharma Sciences Rights Issue 2024 rights issue size is ₹449.95 Crores.
| DSJ keep Learning Limited | Solara Active Pharma Sciences Ltd | |
|---|---|---|
| Issue Size | 6,81,24,036 shares | 1,19,98,755 shares |
| Issue Size (Amount) | ₹6.81 Crores | ₹449.95 Crores |
| Issue Price | ₹1 per share | ₹375 per share |
| Face Value | ₹1 per share | ₹10 per share |
Find all the important dates related to the rights issue. The record date of DSJ keep Learning Rights Issue 2024 is May 14, 2024 while record date of Solara Active Pharma Sciences Rights Issue 2024 is May 15, 2024.
| DSJ keep Learning Limited | Solara Active Pharma Sciences Ltd | |
|---|---|---|
| Record Date | May 14, 2024 | May 15, 2024 |
| Credit of Rights Entitlements | Jun 28, 2024 | May 27, 2024 |
| Bid/Offer Opens On | May 29, 2024 | May 28, 2024 |
| Renunciation of Rights Entitlements | Jun 03, 2024 | Jun 05, 2024 |
| Bid/Offer Closes On | Jun 06, 2024 | Jun 11, 2024 |
| Deemed Date of Allotment | Jun 14, 2024 | Jun 19, 2024 |
| Credit Date | Jun 19, 2024 | Jun 19, 2024 |
| Listing Date | Jun 20, 2024 | Jun 20, 2024 |
Comparison of DSJ keep Learning Rights Issue 2024 and Solara Active Pharma Sciences Rights Issue 2024 financial data, including total revenue, PAT, and net worth. The table below also includes a list of all relevant documents like the Application Form and Letter of Offer. Related Parties like Lead Manager and Registrar are also mentioned in this section.
| DSJ keep Learning Limited | Solara Active Pharma Sciences Ltd | |||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financial | DSJ keep Learning Limited Financial Information (Restated Standalone)DSJ keep Learning Limited's revenue increased by 16.09% and profit after tax (PAT) dropped by -95.11% between the financial year ending with March 31, 2023 and March 31, 2022.
|
Solara Active Pharma Sciences Ltd Financial Information (Restated Consolidated)Solara Active Pharma Sciences Ltd's revenue increased by 13.82% and profit after tax (PAT) rose by 61.85% between the financial year ending with March 31, 2023 and March 31, 2022.
|
||||||||||||||||||||||||||||||||||||||||
Add a public comment...
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
